Industrial Organ
on Chip Technology

What you can do:


→ Recreate disease- and tumor-specific microenvironments
→ Enable monitoring of pathophysiology in real time
→ Study metastasis and immune interactions
→ Test novel therapies and drug combinations
→ Study systemic cancer effects with multi-organ interactions

‍

For example:

We have developed and validated breast and lung cancer models on chip. MCF-7 cells and spheroid fragments were cultured under flow, revealing altered cancer stem cell marker expression and differential drug response to 4-hydroxytamoxifen compared to static cultures

What you can do:

→ Patient-derived cell cultures and organoids on chip
→ Patient – specific personalised testing iPCSs
→ Predict individual drug responses
→ Support personalized therapy selection

For example:

Patient-derived NSCLC organoids were cultured in chips and exposed to cisplatin, demonstrating patient-specific cytotoxicity and biomarker expression under dynamic conditions

What you can do:

→ Validate novel drug candidates using physiologically relevant human models
→ Predict human responses earlier
→ Reduce costly late-stage failures
→ Robust and reproducible high-throughput assays

What you can do:


→ Organ-specific toxicity detection
→ Chronic and acute exposure testing
→ Enable long-term exposure studies and low-dose effects analysis